December 2025 FDA Recall Drug by Handelnine Global Llc
D-0332-2026 - CGMP Deviations

This Class I drug recall was voluntarily initiated by Handelnine Global Llc on December 22, 2025 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed to one customer in NY. and the recall is currently ongoing.

Recall Number: D-0332-2026

Reason for Recall
CGMP Deviations: product found to contain lead.
Initiated
12-22-2025
Reported
02-11-2026
Quantity
4 bottles /30 capsules each

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
98165
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
HANDELNINE GLOBAL LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Press Release
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Product was distributed to one customer in NY.
Product Description About Product Description
Full technical description of the product.
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Batch or Lot Expiration Information

Lot# Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028